Novavax said it has a deal with SK Bioscience to manufacture the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning.
Novavax (ticker: NVAX) said its development and supply agreement with the South Korean firm will help it supply its vaccine, NVX-CoV2373, to global markets, including South Korea. SK is set to start production this month.
Keep the covids movirng, raw cash.
This is the level of significance for signaling my covid betting scheme, and naturally the market agreed. This is not breathtaking,bu tit stands out, the the Putin vaccine, the sniffle anti-bodies from UCSF. My bet is that we get certainty on covid sometime late i 2021. Two quarters from now much more will be known, the coin toss looking like an even split.
The Fama information processor in action. It literally measures the agglomeration rate, events that lead to a visible value chain. The labs are encoding a production system to kill covid, a structured queue, a generator. A martingale and bound commutative operator organized as an assembly line.
No comments:
Post a Comment